Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DFD-08
- Development stage
- Discontinued
- Lead developer
- Dr. Reddy's Laboratories
- Modality
- Small Molecules
01
Overview
DFD-08 is a **small-molecule dermatology candidate** reportedly developed by **Dr. Reddy's Laboratories** for **keratosis**. Publicly accessible sources identify it only at a high level as a chemical drug in skin and musculoskeletal disease, with no reliable disclosure of its exact active ingredient, molecular structure, precise mechanism of action, formulation details, or clinical pharmacology. Available evidence suggests that the program did not progress meaningfully in development and appears to be inactive or without current development progress.
Beyond the preview
Go deeper on DFD-08.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DFD-08.